BioTech
-
Binance’s Founder Plans a Comeback Even as He Faces Prison Time
He enjoyed a home-cooked dinner in Montana with a former U.S. senator. He visited Telluride, Colo., and Moab, Utah, a…
Read More » -
Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement
A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care activist investor Alex Denner of…
Read More » -
Morphosys cancer drug, House bill on China biotechs
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Ono Pharmaceutical to acquire Deciphera Pharma for $2.4 billion
Ono Pharmaceutical of Japan said Monday it will acquire Deciphera Pharmaceuticals, a Boston-based maker of cancer drugs, for $2.4 billion. …
Read More » -
MorphoSys faces serious safety risk related to cancer drug, pelabresib
MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for myelofibrosis and centerpiece of its…
Read More » -
STAT+: Bernie Sanders targets ‘outrageously high price’ of Ozempic
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Adam’s Biotech Scorecard :Profiting from ‘legal’ insider trading isn’t always easy
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to…
Read More » -
Bristol Myers Squibb CEO Christopher Boerner outlines plans
Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a…
Read More » -
STAT+: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede
Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses. Total revenue was slightly weak…
Read More » -
Obesity drug spending, Novo Nordisk and insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More »